PDF-NATIONAL POLICY FOR CONTAINMENT OF ANTIMICROBIAL RESISTANCE INDIA

CONTAINMENT OF ANTIMICROBIAL RESISTANCE INDIA 2011 Directorate General of Health Services Mini stry of Health Family Welfare Nirman Bhawan New Delhi 1 Developed u nder t he C hairpersonship o. JMH House staff Orientation 2012. Lilian Abbo, MD. Assistant Professor Clinical Infectious Diseases. Laura Smith, . PharmD. . Infectious Diseases Clinical Pharmacist. What is Stewardship?. Selection. Martha Gyansa-Lutterodt. Director Pharmaceutical Services. Outline. The challenge and Policy assessment . S. ituation analysis. Global Action Plan (GAP). Aligning the GAP to Ghana’s Policy Framework. N. gonorrhoeae. . A Review. INTRODUCTION. Progressive antimicrobial resistance in . Neisseria gonorrhoeae . is an emerging public health threat. The Public Health Agency of Canada (the Agency) released updated recommendations in July 2013 for the diagnosis, treatment, follow-up and reporting of gonorrhea. Presenter. date. Supporting healthcare professionals . in the fight against resistance. Expand the standardized antimicrobial web based PPS at a global scale to collect consistent, valid and comparable antimicrobial prescribing data.. Cody Loveland, MPH. Wyoming Department of Health. Outline . Overview of CDC Guidance. Containment Strategy. Epidemiology of . Antibiotic Resistance . in . Wyoming. Antibiotic Resistance Laboratory Network. What are antibiotics?. Definition: chemicals produced by one microorganism to kill or inhibit the growth of other microorganisms. Now included the semi-synthetic antibiotics. Effective against bacteria. a pharmaceutical industry perspective. 17. th. November 2018. Dr Bryan Deane. Dept of Research, Medical & Innovation . Introduction – the ABPI; the biopharmaceutical industry. AMR: the issue. Ireland. Quarter 1-4 2017. 20. th. June 2018. KEY POINTS, 2017 (General). Increasing numbers of invasive infections in recent . years due to the following pathogens. : . K. . pneumonaie. , . P. . aeruginosa, S. . Resistance : T ackling a crisis for the health and wealth of nations The Review on Antimicrobial Resistance Chaired by Jim O’Neill December 2014 Contents What is antimicrobial resistance? RESISTANCE Interagency Task Force on Antimicrobial Resistance Co - Chairs: Centers for Disease Control and Prevention Food and Drug Administration National Institutes of Health Participating Agencie s CC – 14/ UNIT - 7. Azidothymidine Antibiotic Resistance. Zidovudine (AZT). A synthetic pyrimidine (thymidine) analogue. AZT is converted to its triphosphate form by cellular thymidine kinase. It binds preferentially to HIV – reverse transcriptase resulting in chain termination. . Dmitry Makarov. Department of Feed and Feed Additives safety . . ANTIMICROBIAL RESISTANCE (AMR) IS A GLOBAL THREAT TO MANKIND. *. World Health Organization , author. Report on the burden of endemic health care-associated infection worldwide. Geneva: WHO. 1. 1. Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings//BMC Infectious Diseases.- volume 19, Article number: 768 (2019) . Educational MODULE. November 2020. antibiotics and other antimicrobials becoming less effective. infections being increasingly difficult or impossible to treat.. For patients, this results in prolonged illness and sometimes death.. Learn more about AMR, its impact on the.